Plaque-type psoriasis inhibitors
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference122 articles.
1. Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis;Esposito;Expert Rev. Clin. Immunol.,2020
2. Anti-IL17 therapies for psoriasis;Silfvast-Kaiser;Expert Opin. Biol. Ther.,2019
3. Risankizumab in the treatment of psoriasis–literature review;Banaszczyk;Reumatologia,2019
4. The IL-17 family of cytokines in psoriasis: IL-17A and beyond;Brembilla;Front. Immunol.,2018
5. Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials;Cui;Int. Immunopharmacol.,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Topical anti-TNF-a ssDNA aptamer decreased the imiquimod induced psoriatic inflammation in BALB/c mice;Cytokine;2023-12
2. Serum total bilirubin and one-year prognosis of patients with coronary artery disease and psoriasis;iScience;2023-07
3. Deucravacitinib: The First FDA-Approved Oral TYK2 Inhibitor for Moderate to Severe Plaque Psoriasis;Annals of Pharmacotherapy;2023-06-21
4. Selection and characterization of a new human Interleukin-17A blocking DNA aptamer using protein-SELEX;Biochemical and Biophysical Research Communications;2022-12
5. Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model;International Immunopharmacology;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3